COLOPLAST A/S |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 906 DKK | +1.09% |
|
-0.18% | +17.36% |
| Feb. 27 | Certain B Shares of Coloplast A/S are subject to a Lock-Up Agreement Ending on 27-FEB-2024. | CI |
| Feb. 14 | COLOPLAST : Q1 24: Many more positives beyond the margin beat |  |
Presenter SpeechAleksandra Dimovska (Executives)Hi, everyone. Welcome to Coloplast. It is real...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Coloplast A/S specializes in the design, manufacturing, and marketing of disposable medical products. Net sales break down by family of products as follows:
- hygiene products (43.4%): urine bags, plugs, urinary testing systems and sets, etc.;
- ostomy care products (36.8%): bags and equipment used following intestinal operations;
- wound care and skincare products (11.9%): wound dressings, bandages, creams and gels;
- voice and respiratory care products (7.9%): voice prostheses for speaking, adhesives, laryngectomy cannulas for breathing, hands-free speaking devices, etc.
Net sales are distributed geographically as follows: Denmark (1.4%), the United States (21%), the United Kingdom (14%), France (10.8%) and other (52.8%).
Calendar
2024-05-07
- Q2 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
906
DKK
Average target price
917.1
DKK
Spread / Average Target
+1.22%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +17.36% | 28.79B | |
| -37.45% | 2.79B | |
| -10.36% | 2.74B | |
| -3.64% | 1.98B | |
| -2.59% | 1.92B | |
| -14.29% | 1.6B | |
| -8.77% | 1.2B | |
| +14.59% | 1.15B | |
| +1.88% | 1.05B | |
| -6.29% | 1.05B |
- Stock Market
- Equities
- COLO B Stock
- News Coloplast A/S
- Transcript : Coloplast A/S - Special Call
